CONSORT diagram: NSABP Protocols B-30, B-31, B-34, and B-38. BC

Toxicity of external beam accelerated partial-breast irradiation (APBI) in adjuvant therapy of early-stage breast cancer: prospective randomized study, Radiation Oncology

Final Planned Joint Analysis of Overall Survival from NSABP-B-31 and NCCTG-N9831

CONSORT diagram: NSABP Protocols B-30, B-31, B-34, and B-38. BC=Breast

Comparison of Breast Cancer Recurrence and Outcome Patterns Between Patients Treated From 1986 to 1992 and From 2004 to 2008

The impact of erythropoiesis-stimulating agents administration concomitantly with adjuvant anti-HER2 treatments on the outcomes of patients with early breast cancer: a sub-analysis of the ALTTO study

PIK3CA alterations and benefit with neratinib: analysis from the randomized, double-blind, placebo-controlled, phase III ExteNET trial, Breast Cancer Research

Impact of HER2-low status for patients with early-stage breast cancer and non-pCR after neoadjuvant chemotherapy: a National Cancer Database Analysis

Alterations in immune cell phenotype and cytotoxic capacity in HER2+ breast cancer patients receiving HER2-targeted neo-adjuvant therapy

CONSORT 2010 explanation and elaboration: Updated guidelines for